Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
31 March 2020 | Story Leonie Bolleurs | Photo Gerhard de Jager
Prof Linda Basson recently returned from a three-month research expedition in Antarctica. Here she is, relaxing on the ice with the ever-inquisitive Adelie penguins having a gander at these strangers in their snowy world.
Prof Linda Basson recently returned from a three-month research expedition in Antarctica. Here she is, relaxing on the ice with the ever-inquisitive Adelie penguins having a gander at these strangers in their snowy world.

Very little is known about the parasites of Antarctica, which is a highly productive part of the oceans. These small organisms can be used very successfully to determine the health of this fragile ecosystem.

“Our research data can make significant contributions to the biodiversity of parasites, for a start. The data can also be very valuable to indicate the overall health of this large ecosystem – an ecosystem that drives many of the life-giving processes on our planet.” This is the belief of Prof Linda Basson from the Department of Zoology and Entomology at the University of the Free State (UFS). 

She is an aquatic parasitologist who concentrates on various parasites from a wide range of hosts, including vertebrates (fish and amphibians) and invertebrates (plankton, urchins, starfish, sea cucumbers and red-bait).

Prof Basson, together with PhD student Gerhard de Jager, was invited by Prof Isabelle Ansorge, Head of the School of Oceanography, University of Cape Town, to join her research team on the South African National Antarctic Programme (SANAE) Voyage 59 to Antarctica. 

Widen the scope of research 
“Our aim on this trip was to determine how we can collaborate with the various oceanographers to widen the scope of research normally performed on these voyages, in order to also include parasitological aspects. Once we arrived on the continent of Antarctica, we worked to collect a range of hosts from the Southern Ocean to screen these for the whole array of parasites,” she explains. 

No research of any kind on aquatic parasites has ever been done in Penguin Bukta and Akta Bukta, the specific areas where Prof Basson was based with other scientists and the rest of the Agulhas crew.

She adds: “Our research will contribute to the wider knowledge of parasites in marine environments, but specifically in this area where little to nothing is known.”

A chance of a lifetime 
“Antarctica was literally one of the top research destinations on my bucket list. Travelling to and working in Antarctica is a lifelong dream of mine. It was a chance of a lifetime that I could not miss out on,” says Prof Basson. 

Sharing her experience, she says a typical day on board the SA Agulhas II in Antarctica will start with a cup of good, quality coffee and a look at the prevailing weather on the stern of the ship. 

“One would always be amazed by the beautiful, ceaselessly changing water, the restless sea ice and the impressive ancient ice shelf in very invigorating temperatures, while an ethereal Snow Petrel swirls past and the occasional Adelie penguin comes to gaze and contemplate the presence of this large red structure floating in their habitat and obscuring their view. After tearing yourself away from this, the rest of the day would be spent either in the well-equipped laboratory working through collected samples, or else planning the next exciting collection in the intensely cold water.”

Remarkable journey 
To eternalise memories of this unique experience of almost three months, Prof Basson says that, “One cannot go without a fully charged camera with a large SD card, ready to capture the many facets of this exceedingly fragile but enchanting world of ice and sky, ever changing and all in innumerable shades of white”.

“This truly remarkable journey will forever be associated with a myriad of brilliant highlights.”

Finding it extremely difficult to single out a specific highlight, she listed a long list of memorable events, but as a scientist she will always remember “realising the wealth and cornucopia of microscopic life present in the southernmost of our oceans and seeing this first-hand under the microscope”.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept